Tessella. Complex problems. Solved.

Posts Tagged ‘Adaptive clinical trials’

Webinar: Implementing Bayesian Response Adaptive Trials, Tuesday, January 18, 2011 — 10:00 a.m. Eastern Time (U.S.) and Thursday, January 20, 2011 — 1:00 p.m. Eastern Time (U.S.)

Tuesday, December 14th, 2010

Join Tom Parke, Head of Clinical Trial Solutions at Tessella and Damian McEntegart, Senior Director of Statistics and Product Support at Perceptive Informatics for a webinar on Implementing Bayesian Response Adaptive Trials, taking place on Tuesday, January 18, 2011 at 10:00 a.m. Eastern Time (U.S.), 3:00 pm BST (U.K.) and Thursday, January 20, 2011 at 1:00 pm Eastern Time (U.S.), [...]

Perceptive User Group Meeting; October 26-28, 2010, Philadelphia, PA

Monday, October 18th, 2010

Tessella’s Head of Clinical Trials Solutions Tom Parke, will be speaking at the Perceptive User Group Meeting taking place on October 26-28, 2010 in Philadelphia, PA. Tom Parke be giving a talk on: What adaptive clinical trials promise What it takes to run an adaptive trial What can go wrong and how to prevent it, [...]

6th Annual Biomarkers Congress 2011; February 23-24th, 2011, Manchester, UK

Sunday, September 19th, 2010

Tessella are proudly sponsoring the 6th Annual Biomarkers Congress taking place on February 23-24th, 2011 in Manchester, UK. Tom Parke, Head of Clinical Technologies at Tessella will be speaking at the event.  His talk will be on Incorporating Biomarkers into Trial Designs. To find out more or to register on-line visit http://www.biomarkers-congress.com

Bio-IT World: FACTS 2 Makes Most Clinical Trials Eligible for Design Simulation

By Deborah Borfitz The first upgrade to a one-of-a-kind simulation tool co-developed by Tessella and Berry Consultants significantly enlarges the proportion of clinical studies that can benefit from simulation of the design…read more

Accelerating Development & Advancing Personalized Therapy (ADAPT 2010); September 13-16th, 2010, Hyatt Regency Crystal City, Arlington, VA

Thursday, September 16th, 2010

Tessella are corporate sponsors of ADAPT 2010, taking place on September 13-16th, 2010 at the Hyatt Regency Crystal City, Arlington, VA, USA. Tom Parke, head of clinical trial solutions at Tessella is a speaker at the event and will be giving a talk on Adpative Clinical Trials and Biomarkers and Scott Berry, President and Senior Statistical [...]

PRESS RELEASE: Tessella and Berry Consultants launch FACTS™ 2

New simulation tool helps drug development team optimise clinical trials Oxford, UK | Texas, US | September 14, 2010. Tessella, the information technology and consulting services company selected by R&D, science and engineering leaders for business-critical assignments and Berry Consultants, leaders in the Bayesian approach to medical statistics announce the availability of their trial design [...]

Bio-IT World Conference and Exhibition 2011; April 12-14, 2011, World Trade Centre, Boston, US

Friday, September 10th, 2010

Tessella are platinum sponsors of  Bio-IT World Conference and Exhibition 2011, taking place at the World Trade Centre in Boston, US on April 12-14, 2011. To find out more or to register online visit http://www.bio-itworldexpo.com/

Drug Discovery World: ‘Scientists Instincts Often Impaired’

Optibrium, and Tessella, the information technology and consulting services company and world leaders in digital preservation technology, today published a new paper highlighting that scientists’ instincts may not always lead them to making good drug discovery decisions…read more

Press Release: New paper from Optibrium and Tessella illustrates scientists’ instincts are often impaired by human cognitive biases when making drug discovery decisions

CAMBRIDGE | OXFORD UK, July 8 2010 – Optibrium, a provider of software solutions for drug discovery, and Tessella, the technology and consulting services company, today published a new paper highlighting that scientists’ instincts may not always lead them to making good drug discovery decisions. The challenges of decision-making arise from the importance of multiple/conflicting [...]

LabBulletin: New paper from Optibrium and Tessella illustrates scientists’ instincts are often impaired by human cognitive biases when making drug discovery decisions

Optibrium, a provider of software solutions for drug discovery, and Tessella, the information technology and consulting services company and world leaders in digital preservation technology, today published a new paper highlighting that scientists’ instincts may not always lead them to making good drug discovery decisions…read more